Crossref
Monoclonal Antibody Therapy in a Lymphoma Patient with Severe COVID-19
Malignancy Spectrum · 2026 · 3 (1) · 35
DOI: 10.15302/msp.2026.0002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Malignancy Spectrum, 2026.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
(2026). Monoclonal Antibody Therapy in a Lymphoma Patient with Severe COVID-19. Malignancy Spectrum, 3(1), 35. https://doi.org/10.15302/msp.2026.0002
Vancouver
Monoclonal Antibody Therapy in a Lymphoma Patient with Severe COVID-19. Malignancy Spectrum. 2026;3(1):35. doi:10.15302/msp.2026.0002
BibTeX
@article{euvimed2026,
title = {Monoclonal Antibody Therapy in a Lymphoma Patient with Severe COVID-19},
journal = {Malignancy Spectrum},
year = {2026},
volume = {3},
number = {1},
pages = {35},
doi = {10.15302/msp.2026.0002}
}
EUVIMED